• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突尼斯社区获得性尿路感染中产超广谱β-内酰胺酶大肠埃希菌的特征。

Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia.

机构信息

Laboratoire de Recherche Résistance aux Antimicrobiens, Faculté de Médecine, Hôpital Charles Nicolle, Tunis, Tunisia.

出版信息

Microb Drug Resist. 2013 Jun;19(3):231-6. doi: 10.1089/mdr.2012.0172. Epub 2013 Jan 30.

DOI:10.1089/mdr.2012.0172
PMID:23363379
Abstract

This study was conducted to investigate the molecular epidemiology of extended spectrum β-lactamase (ESBL)-producing Escherichia coli in community-acquired (urinary tract) infections (CA-UTI) in Tunisia. Between January 2007 and December 2009, 15 E. coli isolates were collected at the laboratory of microbiology of Charles Nicolle Hospital of Tunis. Microbial identification was done with conventional methods. Antibiotic susceptibility was determined by disk diffusion method and ESBL detection was done with double-disk synergy test. ESBL typing was performed by polymerase chain reaction (PCR) and sequencing. Phylogenetic groups, virulence factors, and sequence type (ST)131 were determined by PCR. Genetic relatedness between strains was examined by pulsed-field gel electrophoresis (PFGE) after restriction with XbaI. The prevalence of ESBL-producing E. coli in CA-UTI was 0.046%. The majority of isolates were multidrug resistant. ESBL types were CTX-M-15 (n=13) and SHV-12 (n=2). The most common phylogenetic group was B2 (n=11) and virulence score was greater than or equal to 9 in nine strains. PFGE revealed 12 clusters. The majority of isolates (n=14) belonged to ST131 clone and 11 of them were CTX-M producers. In conclusion, this is the first detailed documentation of CA-ESBLs producing E. coli in Tunisia. Of particular concern is the emergence in our community of the highly diffusing CTX-M-15-B2-ST131 E. coli clone, which requires strengthening surveillance measures to countervail this emergent public health problem.

摘要

本研究旨在调查突尼斯社区获得性(尿路感染)感染(CA-UTI)中产生超广谱β-内酰胺酶(ESBL)的大肠杆菌的分子流行病学。在 2007 年 1 月至 2009 年 12 月期间,在突尼斯 Charles Nicolle 医院的微生物学实验室收集了 15 株大肠杆菌分离株。微生物鉴定采用常规方法。药敏试验采用纸片扩散法,ESBL 检测采用双纸片协同试验。ESBL 型别通过聚合酶链反应(PCR)和测序进行。通过 PCR 确定了进化群、毒力因子和 ST131 型。通过 XbaI 限制的脉冲场凝胶电泳(PFGE)检测菌株间的遗传相关性。CA-UTI 中 ESBL 产大肠埃希菌的流行率为 0.046%。大多数分离株为多药耐药。ESBL 型别为 CTX-M-15(n=13)和 SHV-12(n=2)。最常见的进化群是 B2(n=11),9 株菌的毒力评分大于或等于 9。PFGE 显示 12 个聚类。大多数分离株(n=14)属于 ST131 克隆,其中 11 株为 CTX-M 产生菌。总之,这是突尼斯首例详细记录的 CA-ESBL 产大肠埃希菌。特别令人关注的是我们社区中高度扩散的 CTX-M-15-B2-ST131 大肠杆菌克隆的出现,这需要加强监测措施来应对这一新兴的公共卫生问题。

相似文献

1
Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia.突尼斯社区获得性尿路感染中产超广谱β-内酰胺酶大肠埃希菌的特征。
Microb Drug Resist. 2013 Jun;19(3):231-6. doi: 10.1089/mdr.2012.0172. Epub 2013 Jan 30.
2
Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.质粒介导产AmpCβ-内酰胺酶的大肠杆菌在奥克兰社区引起尿路感染,可能对常用抗菌药物耐药。
N Z Med J. 2015 Mar 13;128(1410):50-9.
3
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.芝加哥地区产超广谱β-内酰胺酶大肠埃希菌的分子特征:社区医院中 CTX-M-15 型大肠埃希菌流行率较高。
Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31.
4
Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.土耳其:另一个受社区获得性产CTX-M-15的大肠杆菌克隆O25-ST131影响的国家。
J Antimicrob Chemother. 2008 Aug;62(2):284-8. doi: 10.1093/jac/dkn181. Epub 2008 May 2.
5
Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.从住院和非住院患者中分离的大肠埃希菌产生的超广谱β-内酰胺酶的特性:导致尿路感染的 CTX-M-15 产菌株的出现。
Microb Drug Resist. 2010 Jun;16(2):129-34. doi: 10.1089/mdr.2009.0132.
6
High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.在捷克共和国社区获得性感染的产CTX-M型大肠杆菌中,ST131的高流行率。
Microb Drug Resist. 2015 Feb;21(1):74-84. doi: 10.1089/mdr.2014.0070. Epub 2014 Sep 4.
7
Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.韩国社区和医院中产extended-spectrum β-lactamase 的大肠杆菌的分子流行病学:CTX-M-15 型 CTX-M-15 型 ST131 的出现。
BMC Infect Dis. 2012 Jun 29;12:149. doi: 10.1186/1471-2334-12-149.
8
CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.哥伦比亚巴耶杜帕尔社区获得性尿路感染中产 CTX-M 型大肠埃希菌和肺炎克雷伯菌的分离
Braz J Infect Dis. 2012 Sep-Oct;16(5):420-5. doi: 10.1016/j.bjid.2012.05.001. Epub 2012 Sep 8.
9
Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.女性尿液中大肠埃希菌CTX-M型超广谱β-内酰胺酶的社区出现情况
J Antimicrob Chemother. 2007 Jul;60(1):140-4. doi: 10.1093/jac/dkm144. Epub 2007 May 11.
10
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.携带超广谱β-内酰胺酶的大肠埃希菌引起社区获得性尿路感染的危险因素。
J Antimicrob Chemother. 2006 Apr;57(4):780-3. doi: 10.1093/jac/dkl035. Epub 2006 Feb 21.

引用本文的文献

1
Enterobacter cloacae from urinary tract infections: frequency, protein analysis, and antimicrobial resistance.尿路感染中的阴沟肠杆菌:发生率、蛋白质分析及抗菌药物耐药性
AMB Express. 2024 Feb 8;14(1):17. doi: 10.1186/s13568-024-01675-7.
2
Phenotypic characterization and epidemiology of extended-spectrum -lactamase-producing strains from urinary tract infections in Garoua, Cameroon.喀麦隆加鲁阿地区尿路感染中产超广谱β-内酰胺酶菌株的表型特征及流行病学研究。
Front Public Health. 2023 Jun 29;11:1187934. doi: 10.3389/fpubh.2023.1187934. eCollection 2023.
3
Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa.
非洲耐碳青霉烯类和多黏菌素类大肠埃希菌和肺炎克雷伯菌重叠威胁的回顾与分析。
Antimicrob Resist Infect Control. 2023 Apr 4;12(1):29. doi: 10.1186/s13756-023-01220-4.
4
Susceptibility and Virulence of Isolated from Urinary Tract Infections in Benin.贝宁尿路感染分离株的易感性和毒力
Microorganisms. 2023 Jan 14;11(1):213. doi: 10.3390/microorganisms11010213.
5
Whole Genome-Based Characterization of Multidrug Resistant Enterobacter and Klebsiella aerogenes Isolates from Lebanon.黎巴嫩多药耐药肠杆菌和产气克雷伯菌分离株的全基因组特征分析。
Microbiol Spectr. 2023 Feb 14;11(1):e0291722. doi: 10.1128/spectrum.02917-22. Epub 2023 Jan 18.
6
Detection of Clones B2-ST131-C2 and A-ST617 in Producing Both CTX-M-15 and CTX-M-27 from Tunisian Community Patients.在突尼斯社区患者中检测到同时产生CTX-M-15和CTX-M-27的克隆B2-ST131-C2和A-ST617 。
Antibiotics (Basel). 2022 Sep 29;11(10):1329. doi: 10.3390/antibiotics11101329.
7
Rapid Detection of Beta-Lactamases Genes among in Urine Samples by Using Real-Time PCR.实时 PCR 在尿液样本中检测β-内酰胺酶基因。
Biomed Res Int. 2022 Aug 8;2022:8612933. doi: 10.1155/2022/8612933. eCollection 2022.
8
Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania.早在2004年,在坦桑尼亚达累斯萨拉姆就已检测到在医院获得性和社区获得性尿路感染的肠杆菌科细菌中存在CTX-M-15β-内酰胺酶。
BMC Infect Dis. 2017 Apr 17;17(1):282. doi: 10.1186/s12879-017-2395-8.
9
Extended-spectrum ß-Lactamase-producing Enterobacteriaceae as a Common Cause of Urinary Tract Infections in Sri Lanka.产超广谱β-内酰胺酶肠杆菌科细菌作为斯里兰卡尿路感染的常见病因
Infect Chemother. 2016 Sep;48(3):160-165. doi: 10.3947/ic.2016.48.3.160.
10
Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.大肠杆菌ST131和肺炎克雷伯菌ST258的流行潜力:一项系统评价和荟萃分析
BMJ Open. 2016 Mar 17;6(3):e009971. doi: 10.1136/bmjopen-2015-009971.